Abstract-Non-nucleoside analogs of the pyrrolopyrimidine nucleosides toyocamycin, sangivamycin and thiosangivamycin have been synthesized and their cytotoxicity in mammalian cells determined. While studying the effects of Rhioamide-substituted analogs on cell growth, we observed an interesting phenomenon in which cells recovered spontaneously from growth inhibition during extended incubations. HPLC studies demonstrated that the 5-thioamide moiety of several structurally dissimilar 7-substituted 4-aminopyrrolo[2,3-djpyrimidines, including thiosangivamycin, is unstable in cell culture medium and is converted to the corresponding 5-nitrile with a half-life of approximately 48 hr. In contrast, different substituents at the 4-position of the heterocycle significantly affected the stability of the 5-thioamide moiety. Conversion of the thioamide to the nitrile was caused by components in the cell culture medium, not components of serum. The above observations demonstrate that caution should be exercised in interpreting biological data obtained in vitro for 5-thioamide pyrrolo[2,3-dlpyrimidines.
The pyrrolo [2,3-dlpyrimidine nucleoside antibiotics toyocamycin (la, Table 1 ) and sangivamycin (lb) originally were isolated from different strains of streptomyces in 1956 and 1963, respectively [l, 21. The total synthesis of these compounds was reported in 1969 by Townsend and coworkers [3] . A synthetic analog, thiosangivamycin (lc), was described in 1970 by this same research group [4] . All three compounds (la-c) are highly toxic to mammalian cells and have been evaluated as potential anti-cancer agents [.5,6] . Sangivamycin was advanced to phase I clinical trials, and a report on its toxicity has been published [7] .
As part of our ongoing research involving pyrrolo [2,3-d] pyrimidines as potential antiviral agents [8-141, we recently described the synthesis and activity against HCMVt of a number of nonnucleoside derivatives related to toyocamycin, sangivamycin and thiosangivamycin (la-c) [15] . We have expanded our studies in this area and now have synthesized a number of closely related compounds (Z-6). While studying the cytotoxicity profile of these new analogs, we observed an unusual phenomenon in which cells spontaneously recovered from growth inhibition during extended incubation times. An investigation and an explanation of this phenomenon follows.
MATERIALS AND METHODS

Materials.
Toyocamycin, sangivamycin and thiosangivamycin were obtained from the library of compounds in the laboratory of one of us (L.B.T.). Compounds 2 and 3 were synthesized in four or five steps ,from the known 2-amino-5-bromo-3,4-dicyanopyrrole [16] by a modification of the procedure described in Ref. 15 . Compounds 4-6 were synthesized from the kev intermediate 4-chloro-7 -[(i -methoxyethoxy)m&hyl]pyrrolo[2,3
-d] -ovrimidine-5-carbonitrile eenerated bv a modifi&ion of the procedure discribed pre;iously [17] . No impurities were detected in the 'H NMR of all compounds examined and C-H-N analysis of these compounds was within the acceptable +0.4% of theoretical values. Details of the synthetic procedures, physical characteristics, and antiviral activity of compounds 2-6 are being published elsewhere.
Cell cultures. KB cells, an established human cell line derived from an epidermal oral carcinoma, were grown in MEM supplemented with 10% calf serum and were subcultured by conventional methods by using 0.05% trypsin plus 0.02% EDTA [8] . The average PDT for KB cells in the absence of drugs was 21 hr. L1210 murine leukemic cells were grown in Fischer's medium supplemented with 10% heat-802 T. E. RENAU et al. inactivated (56", 30 min) horse serum and were subcultured by serial dilution. All cell lines were screened periodically for Mycoplasma contamination and were negative.
Cytotoxicity studies. The cytotoxicity of compounds la-c to 3a-c was determined initially in KB cells by a staining method previously described [18] and in an L1210 cell growth assay [19] . In more detailed studies, the inhibitory effect of compound 2c was evaluated and PDTs were determined in a KB cell growth assay [20] . PDTs are significantly longer in cells whose growth is inhibited, or whose absolute numbers decrease as a result of toxicity affecting their growth. PDTs were calculated by means of a least squares program fitting the exponential portion of a growth curve. For growth studies with KB and L1210 cells, growth rates were calculated from determinations of the number of cells at 0, 24, 48, 72 and 96 hr in the presence of selected concentrations of the test compound. Cells were enumerated using a Coulter Counter (Coulter Electronics, Hialeah, FL). Growth inhibition was calculated as the slope of a semi-logarithmic plot of cell number against time for the treated culture as a percent of the control. In both the staining and cell growth studies, the ICKY was defined as the concentration required to decrease the growth rate to 50% of the control rate.
Compound stability assays. The stability of compounds in cell culture medium was investigated by incubating 100 @I concentrations of compounds l-6 at 37" in tightly capped tubes. The compounds were incubated in either Fischer's medium, MEM, or HBS [21] (10 mM HEPES, 137 mM NaCl, 5.4 mM KCl, 0.7 mM Na2HP04, 5.6 mM dextrose, pH 6.5). In all cases, the incubation media contained neither Retention times (RT) were determined by reverse-phase HPLC as described in the text. The A,,,,, (nm) of each compound was determined by UV spectroscopy. cells nor serum. The pH of the medium was monitored and was found to be consistently between 7.5 and 7.8. At selected times during periods extending up to approximately 3 weeks, lOO+L aliquots of medium or buffer were removed and immediately analyzed by reverse-phase HPLC.
Analytical procedures. HPLC of compounds l-6 was performed with a Beckman Ultrasphere ODS reverse-phase column (5 pm, 4.6 mm X 15 cm). HPLC analysis of la-c was adapted from a literature Cytotoxicity and conversion of thiosangivamycin analogs 803 procedure 1221. Compounds la-c were eluted in 30 min using a linear gradient starting with 0.02 M KH2P04 ( H5.6): 60% MeOH/40% Hz0 solution (87: 13, v v) and ending with 100% of the 60% P MeOH/40% HZ0 solution. Elution of compounds 2-6 was accomplished in 70 min using a linear gradient starting with 0.1% trifluoroacetic acid in HZ0 and ending with 50% MeOH. UV absorbance of the compounds was monitored simultaneously at the A,,,,, for the thioamide and nitrile substituted derivatives (Table 2) . Retention times (RT) for compounds l-4 are shown in Table 2 . Peak areas were determined using System Gold Software (Beckman Instruments, Fullerton, CA). The purity of each compound was determined by HPLC before the start of each experiment.
RESULTS
7-Benzyl-substituted 4-aminopyrrolo[2,3-dlpyrimidine derivatives
(Za-t, Table l), related to toyocamycin (la), sangivamycin (lb) and thiosangivamycin (lc), were synthesized and examined for activity against HCMV as potential antiviral agents. Results, described elsewhere [23] , showed that similar to our previous report on 7-alkyl 4-aminopyrrolo [2,3-dlpyrimidines [15] , only the thioamide-substituted derivative (2c) exhibited activity against HCMV [23] . We have expanded the cytotoxicity portion of those studies and now report that the thioamide (2~) was more toxic than the carboxamide (2b) in KB cells, but in L121O cells 2b was more toxic than 2c (Table 1 ). In both cell lines, the nitrile derivative (2a) was the least toxic. Nonetheless, compounds 2a-c were substantially less toxic in both KB and L1210 cells when compared with the parent nucleoside analogs la-c. Compounds 3a-c containing a 2-methoxyethoxy methyl side chain at N-7, were the least toxic compounds of those studied.
More detailed studies on the effect of compound 2c on the growth of uninfected KB cells demonstrated that it suppressed growth at 10 and 32 PM (Fig. 1) . Inhibition observed at 32pM was reversible upon removal of the drug following a 24-hr incubation period (Fig. I) , suggesting that it acts as a cytostatic rather than a cytotoxic agent. Surprisingly, growth resumed even in cultures from which drug was not removed (Fig. 1) . This observation was supported by data from a separate experiment in KB cells where PDTs were calculated at 24-hr intervals up to 72 hr after incubation of 32pM 2c. Over this 72-hr period, the PDT increased from 21 hr in the control to 56 hr in drug-treated cultures during the first 24-hr incubation with 2c. In contrast, the PDT of the drug-treated cultures returned to control values (20 hr compared with 21 hr in the control) during the last 24-hr interval. Similar results were obtained in L1210 cells. Together these results suggested that 2c was being converted to a less toxic compound in vitro. Various possibilities were considered for the basis for this recovery: (i) inactivation of the compound by cellular enzymes, (ii) inactivation by enzymes in the serum, or (iii) degradation in cell culture medium. Cell growth recovery could not be totally attributed to cellular or serum proteins inactivating the compound since preincubation of 100 yM compound 2c in medium without serum for 2 days before the addition of cells eliminated inhibition of L1210 cell growth. In this experiment, L1210 cell growth in drug-treated cultures was comparable to the control values even though the concentration of 2c used was approximately 1.5 times the IQ~. Therefore, we concluded that compound 2c was unstable in cell culture medium alone (without serum) and was spontaneously converting to a relatively non-toxic compound.
To investigate this phenomenon, 100pM compound 2c was incubated in serum-free Fischer's cell culture medium. HPLC analysis was performed on samples of cell culture medium removed at 24-hr intervals. Within the first 48 hr of incubation, more than half of 2c was converted to a new product (Fig.  2) . By 144 hr, nearly all of 2c was converted to this new product. HPLC analysis using both 2a and 2b as markers showed that this new peak co-eluted with the co~esponding nitrile (2a). From this it was calculated that the thioamide (2~) was converted to 2a with a T112 of 41 hr. Upon close examination of the HPLC chromatograms, a small amount of the nitrile, 2a, and a peak which co-eluted with the carboxamide (2b) were observed at t = 0. These trace amounts most likely were impurities in 2c that were not detected by either 'H NMR or C-H-N analysis used to characterize 2~. It should be noted that the peak 2b did not change over the 144-hr incubation period (Fig. 2) To test this question, we investigated the stability of a related series of compounds, 3a-c (Table l) , We chose this series for two reasons: (i) the ether substituent at N-7 of 3a-c was structurally different than the benzyl group of 2a-c and (ii) in contrast to 2a-q 3a-c were non-toxic at 100pM in both KB and L1210 cells (Table 1) . Compound 3c was incubated for 5 days under the conditions described previously.
HPLC analysis demonstrated that 3c was converted to a single product that coeluted with the nitrile, 3a, with a T1jZ of 50 hr. In contrast to the studies with 2c, a peak that co-eluted with the carboxamide, 3b, was not detected from t = 0 through the S-day incubation period. Fig. 3 . Stability of the pyrrolopyrimidine nucleoside thiosangivamycin in cell culture medium. Thiosangivamycin was incubated in Fischer's medium without serum for 11 days. Aliquots were removed at the times indicated and analyzed by HPLC. The peak areas presented in the figure are those determined at the &, for each nucleoside (274 nm for toyocamycin and 292 nm for thiosangivamycin) The peak area at later time points for toyocamycin is greater than the peak area for thiosangivamycin at t = 0 because the molar absorptivity (E) for toyocamycin at 274 nm is greater than the &for thiosangivamycin at 292 nm L3.41.
(lb) and thiosangivamycin (lc) was also studied. Like studies with 2c and 3c, the stability of thiosangivamycin was examined by incubating it in Fischer's medium without serum for 11 days and analyzing samples by HPLC at selected times during this period. The results showed (Fig. 3) that like 2c and 3c, thiosangivamycin was converted to a product that co-eluted with toyocamycin (la) with a TQ = 55 hr. Similar results were obtained by incubating the compound in MEM without serum (T,,, = 41 hr). Like the studies with 3c, a peak that co-eluted with sangivamycin (lb) was not detected from t = 0 through the 11-day incubation period. As with 2a-b and 3a, toyocamycin and sangivamycin were stable under the incubation conditions.
To examine the possible role that components of cell culture medium had on the conversion of the thioamide to the nitrile, a number of studies using buffered solutions or modified cell culture medium were undertaken.
The results showed that contrary to those obtained in Fischer's medium and MEM, incubation of lc in HBS resulted in only a very slow conversion to the nitrile (TI,? > 504 hr). This conversion of thiosangivamycin (lc) to the corresponding nitrile in HBS was > 10 times slower than in cell culture medium, strongly suggesting that components contained in culture medium but not in HBS catalyzed the conversion.
To investigate the role in the conversion of certain components in the medium, the pH of the HBS solution containing lc was increased from 6.5 to 7.6, but this did not affect the stability of the compound.
Additionally, the benzyl derivative 2c was incubated with MEM, which did not contain phenol red and glutamine.
In this Cytotoxicity was determined by measuring the effects of compounds on the growth of KB and L1210 cells. Data are the averages of two or more experiments. The greater than symbol indicates that the ICKY was not reached at the highest concentration tested.
* Not applicable.
medium, the T1/Z was extended from 41 hr to approximately 65 hr demonstrating that although these two components affected the stability of the thioamide moiety, they could not completely account for the conversion.
To investigate whether changes on the heterocycle at sites other than N-7 could affect the stability of the thioamide group, we examined the effect of modifications at the 4-position of 3c on the half-life. In this study, the 4-amino group of compound 3 was replaced with a proton (H), a methylamino group (NHCHs) or a dimethylamino group (N(CHs)z)-compounds 4-6 (Table 3) . Like compounds 3a-c, compounds 4-6 were essentially non-toxic in both KB and L1210 cells with ICKY values >lOO ,uM (Table  3) . Like compounds 1-3, compounds 4-6 were incubated in Fischer's medium, and their stability was monitored by HPLC. The results demonstrated that modifications at the 4-position have a definite effect on the stability of the 5thioamide moiety, whereas changes at N-7 tend not to affect the stability of the .5-thioamide moiety (Table 3) . For example, replacement of the 4-amino group of 3c with a methylamino group (4b) decreased the stability of the thioamide (T,,z = 20 hr). In contrast, replacement with a dimethylamino group (Sb) or a hydrogen (6b) extended the Ti/* from 50 hr for 3c to 150 hr for 5b and 175 hr for 6b. In the case of 5b, we also observed an unidentified peak by HPLC in addition to 5a and Sb. This possible intermediate appeared 24 hr into the incubation and rapidly decreased thereafter. This was the only compound during this entire study where we observed an HPLC peak other than the thioamide or nitrile analogs. pyrrolopyrimidine nucleoside thiosangivamycin and several related analogs are converted to the corresponding nitrile analogs in cell culture medium. The conversion of thiosangivamycin to toyocamycin in cell culture medium has not, to the best of our knowledge, been observed previously. Even if the conversion had occurred in previous studies, there would have been no obvious reason to suspect this since thiosangivamycin and toyocamycin are equally toxic to mammalian cells. The toxicity of thiosangivamycin and toyocamycin arises because both compounds are phosphorylated by adenosine kinase [24] to afford the 5'-monophosphate derivatives that ultimately are incorporated into DNA or RNA [5, 6] . Whether the 5'-monophosphate of thiosangivamycin is converted to phosphorylated toyocamycin is unknown and was not included in the present study. However, our results, uide supru, suggest that this would occur since a variation of the substituent at N-7 does not seem to have a major effect on the conversion.
DISCUSSION
It is interesting that changes at the 4-position can have a major effect on the stability of the 5-thiocarboxamide moiety. This would suggest that the 4-position may play a key role in stabilizing or destabilizing the 5-thioamide group. Results obtained for the 4-substituted amino derivatives (4b and 5b) revealed that increasing the basicity of the amino group at C-4 does not necessarily correlate with an increase or decrease in the stability of the thioamide. Instead, the stability of a substituted thioamide compound seems directly related to the presence or absence of an amino group with a free proton at C-4. Whether modifications at other sites on the heterocycle could affect the stability of the thioamide group is unknown. The present study has established that the The rapid conversion of 2c to its corresponding Chemically, thioamides can be converted to nitriles by treatment with mercuric chloride and methylamine [25, 26] . In the current study, these reagents were not present during the incubation of any of the thioamide-substituted derivatives.
There (5b) to the corresponding nitrile (5a) may support this argument; however, the exact mechanism of how the thioamide is converted to the nitrile in cell culture medium is unknown.
In summary, our results have demonstrated that the 5-thioamide moiety of many 7-substituted 4-aminopyrrolo[2,3-dlpyrimidines is unstable in cell culture medium, and is converted to the corresponding 5-nitrile regardless of the substituent at N-7. In contrast, substituents at the 4-position of the heterocycle significantly affect the stability of the 5-thioamide moiety. Investigators using these or structurally similar compounds should be aware of these results and appreciate that biological data generated in cell culture may be due to a mixture of the thioamide and by-product(s) of the conversion.
